(Bloomberg) — A group of potentially fatal germs that are difficult to treat because they resist antibiotics are becoming more of a threat, according to a U.S. report.

About 4% of U.S. hospitals and 18% of long-term acute care hospitals, such as those that provide ventilation and wound care, had an infection from carbapenem-resistant Enterobacteriaceae, in the first half of 2012, according to a report released Tuesday by Centers for Disease Control and Prevention.

Register or login for access to this item and much more

All Employee Benefit News content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access